[1]Sarkar I, Pati S, Dutta A, et al. Tmemory cells against cancer: Remembering the enemy\[J\]. Cell Immunol, 2019, 338: 27-31.
[2]Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell\[J\]. Nat Rev Cancer, 2012, 12(10): 671-684.
[3]Kaech SM, Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation\[J\]. Nat Rev Immunol, 2012, 12(11): 749-761.
[4]Zhang Y, Joe G, Hexner E, et al. Hostreactive CD8+ memory stem cells in graftversushost disease\[J\]. Nat Med, 2005, 11(12): 1299-1305.
[5]Gattinoni L, Lugli E, Ji Y, et al. A human memory T cell subset with stem celllike properties\[J\]. Nat Med, 2011, 17(10): 1290-1297.
[6]Gattinoni L, Zhong X, Palmer DC, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells\[J\]. Nat Med, 2009, 15(7): 808-813.
[7]Buzon MJ, Sun H, Li C, et al. HIV1 persistence in CD4+ T cells with stem celllike properties\[J\]. Nat Med, 2014, 20(2): 139-142.
[8]Lu X, Song B, Weng W, et al. CD4+ T memory stem cells correlate with disease progression in chronically HIV1infected patients\[J\]. Viral Immunol, 2017, 30(9): 642-648.
[9]Scholz G, Jandus C, Zhang L, et al. Modulation of mTOR signalling triggers the formation of stem celllike memory T cells\[J\]. EBioMedicine, 2016, 4: 50-61.
[10]Kondo T, Morita R, Okuzono Y, et al. Notchmediated conversion of activated T cells into stem cell memorylike T cells for adoptive immunotherapy\[J\]. Nature Commun, 2017, 8: 15338.
[11]Gautam S, Fioravanti J, Zhu W, et al. The transcription factor cMyb regulates CD8+ T cell stemness and antitumor immunity\[J\]. Nat Immunol, 2019, 20(3): 337-349.
[12]Cieri N, Camisa B, Cocchiarella F, et al. IL7 and IL15 instruct the generation of human memory stem T cells from naive precursors\[J\]. Blood, 2013, 121(4): 573-584.
[13]Ku CC, Murakami M, Sakamoto A, et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines\[J\]. Science, 2000, 288(5466): 675-678.
[14]Jeza VT, Li X, Chen J, et al. IL21 augments rapamycin in expansion of alpha fetoprotein antigen specific stemcelllike memory T cells in vitro\[J\]. Pan Afr Med J, 2017, 27: 163.
[15]Kaartinen T, Luostarinen A, Maliniemi P, et al. Low interleukin2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor Tcell expansion\[J\]. Cytotherapy, 2017, 19(9): 1130.
[16]Scheffel MJ, Scurti G, Simms P, et al. Efficacy of adoptive Tcell therapy is improved by treatment with the antioxidant Nacetyl cysteine, which limits activationinduced Tcell death\[J\]. Cancer Res, 2016, 76(20): 6006-6016.
[17]Wu S, Zhu W, Peng Y, et al. The antitumor effects of vaccineactivated CD8+ T cells associate with weak TCR signaling and induction of stemlike memory T cells\[J\]. Cancer Immunol Res, 2017, 5(10): 908-919.
[18]Cai Z, Kishimoto H, Brunmark A, et al. Requirements for peptideinduced T cell receptor downregulation on naive CD8+ T cells\[J\]. J Exp Med,1997, 185(4): 641-651.
[19]Delong JH, Hall AO, Konradt C, et al. Cytokine and TCRmediated regulation of T cell expression of Ly6C and Sca1\[J\]. J Immunol,2018, 200(5): 1761-1770.
[20]Pilipow K, Scamardella E, Puccio S, et al. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumorimmunity\[J\]. JCI Insight, 2018, 3(18): e122299.
[21]Pace L, Goudot C, Zueva E, et al. The epigenetic control of stemness in CD8+ T cell fate commitment\[J\]. Science, 2018, 359(6372): 177-186.
[22]Jaafoura S, de Gor De Herve MG, HernandezVargas EA, et al. Progressive contraction of the latent HIV reservoir around a core of lessdifferentiated CD4+ memory T Cells\[J\]. Nature Commun, 2014, 5(1): 5407.
[23]Vahidi Y, Faghih Z, Talei A, et al. Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells\[J\]. Cell Oncol, 2018, 41(1): 1-11.
[24]Vahidi Y, Bagheri M, Ghaderi A, et al. CD8positive memory T cells in tumordraining lymph nodes of patients with breast cancer\[J\]. BMC Cancer,2020, 20(1): 257.
[25]Faghih Z, Erfani N, Haghshenas MR, et al. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes\[J\]. Immunol Lett,2014, 158(1-2): 57-65.
[26]Nagai Y, Kawahara M, Hishizawa M, et al. T memory stem cells are the hierarchical apex of adult Tcell leukemia\[J\]. Blood, 2015, 125(23): 3527-3535.
[27]Hong H, Gu Y, Sheng SY, et al. The distribution of human stem celllike memory T cell in lung cancer\[J\]. J Immunother, 2016, 39(6): 233-240.
[28]Lee YJ, Park JA, Kwon H, et al. Role of stem celllike memory T cells in systemic lupus erythematosus\[J\]. Arthritis Rheumatol, 2018, 70(9): 1459-1469.
[29]Vignali D, Cantarelli E, Bordignon C, et al. Detection and characterization of CD8+ autoreactive memory stem T cells in patients with type 1 diabetes\[J\]. Diabetes, 2018, 67(5): 936-945.
[30]郑华,林泽杭,张延梅,等. 氧化低密度脂蛋白干预记忆性CD8+T细胞亚群的分化\[J\]. 南方医科大学学报, 2017, 37(8): 1098-1103.
[31]Morrot A. Lifelong protection mediated by stem celllike CD8+ T memory subset cells (Tscm) induced by vaccination\[J\]. Ann Transl Med, 2016, 4(11): 221.
[32]Wang Y, Whittall T, Neil S, et al. A novel mechanism linking memory stem cells with innate immunity in protection against HIV1 infection\[J\]. Sci Rep,2017, 7(1): 1057.
[33]Kondo T, Imura Y, Chikuma S, et al. Generation and application of human inducedstem cell memory T cells for adoptive immunotherapy\[J\]. Cancer Sci, 2018, 109(7): 2130-2140.
[34]Guedan S, Posey JAD, Shaw C, et al. Enhancing CAR T cell persistence through ICOS and 41BB costimulation\[J\]. JCI Insight, 2018, 3(1): e96976.
[35]Alizadeh D, Wong RA, Yang X, et al. IL15 enhances CART cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype\[J\]. Cancer Immunol Res, 2019, 7(5): 759-772.
[36]Gannon PO, Baumgaertner P, Huber A, et al. Rapid and continued Tcell differentiation into longterm effector and memory stem cells in vaccinated melanoma patients\[J\]. Clin Cancer Res,2017, 23(13): 3285-3296. |